Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study

Harald Rittger MD, Jochen Wöhrle MD, Johannes Brachmann MD, Wolfgang Hohenforst-Schmidt MD, Christian Schlundt MD, Sandra Lonke MD, Moritz von Cranach MD, Sinisa Markovic MD, Stephan Achenbach MD, Matthias Waliszewski MD

Objectives: This report provides the results of additional late lumen loss (LLL) analyses the predefined subgroup of diabetics and post hoc analyses of selected lesion morphologies to further elucidate the efficacy of paclitaxel coated balloon (PCB) angioplasty (clinical trials identifier NCT00998439).

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial

Aydin Yildirim MD, Omer Goktekin MD, Sevket Gorgulu MD, Tugrul Norgaz MD, Emre Akkaya MD, Unal Aydin MD, Hale Unal Aksu MD, Ihsan Bakir MD

Background: This study sought to compare various outcomes among a new specifically designed transcatheter paravalvular leak closure (TPVLC) device and the devices that are being utilized off-label.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis

Rocío Angulo-Llanos MD, Fernando Sarnago-Cebada MD, Allan R. Rivera MD, Jaime Elízaga Corrales Md, PhD, Gregorio Cuerpo MD, Jorge Solis MD, Enrique Gutierrez-Ibañes MD, Ricardo Sanz-Ruiz MD, ME Vázquez Álvarez MD, Francisco Fernandez-Avilés MD, PhD

Background: Percutaneous closure of paravalvular leak (PVL) has emerged as an alternative treatment. Predictors of survival and procedural success are unknown.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve

Birgid Gonska MD, Julia Seeger MD, Christoph Rodewald MD, Dominik Scharnbeck MD, Wolfgang Rottbauer MD, Jochen Wöhrle MD

Background: Surgical aortic bioprosthetic valves deteriorate 10 to 20 years after operation. Valve-in-valve implantation with first generation transcatheter aortic valve implantation (TAVI) devices has shown to be feasible. We report a first case series with the new Edwards Sapien 3 valve for transfemoral aortic valve-in-valve implantation.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Percutaneous left atrial appendage occlusion: Effect of device positioning on outcome

Mathias Wolfrum MD, Adrian Attinger-Toller MD, Samera Shakir MD, Steffen Gloekler MD, Burkhardt Seifert PhD, Aris Moschovitis MD, Ahmed Khattab MD, Francesco Maisano MD, Bernhard Meier MD, Fabian Nietlispach MD PhD

Objective: The study in patients with percutaneous left atrial appendage (LAA) occlusion investigates clinical outcomes according to the position of the Amplatzer Cardiac Plug (ACP) disc.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease

Hiroyuki Jinnouchi MD, Shoichi Kuramitsu MD, Tomohiro Shinozaki MPH, Takashi Hiromasa MD, Yohei Kobayashi MD, Takashi Morinaga MD, Kyohei Yamaji MD, Yoshimitsu Soga MD, Shinichi Shirai MD, Kenji Ando MD

Background: Biolimus-eluting stents (BES) have similar efficacy and safety compared with cobalt chromium everolimus-eluting stents (CoCr-EES), whereas it is unclear whether the same applies to small vessel disease. We sought compare clinical outcomes between BES and CoCr-EES in patients with small vessel disease.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR

Cyndi Sosnowski MD, Thomas Matella RT, Louis Fogg PhD, Michel Ilbawi MD, Hosakote Nagaraj MD, Clifford Kavinsky MD, PhD, Andrew R Wolf MD, Karim Diab MD, Massimo Caputo MD, Damien Kenny MD

Objective/Background: Historically, the sole option for patients with a dysfunctional native right ventricular outflow tract (RVOT) requiring re-establishment of pulmonary competence has been surgical PVR. We sought to compare early outcomes of hybrid pulmonary valve replacement (PVR) combining surgical plication of the main pulmonary artery followed by transcatheter PVR, with a contemporary cohort of surgical PVR patients.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation

Weijie Chen MD, Zhiyu Ling PhD, Huaan Du PhD, Wenxin Song MD, Yanping Xu MD, Zengzhang Liu MD, Li Su PhD, Peilin Xiao PhD, Yuelong Yuan MD, Jiayi Lu MD, Jianhong Zhang MD, Zhifeng Li MD, Jiang Shao MD, Bin Zhong MD, Bei Zhou RN, Kamsang Woo MD, Yuehui Yin MD

Background: Renal denervation (RDN) is used to manage blood pressure (BP) in patients with resistant hypertension (rHT), but effectiveness is still a concern, and key arterial portion for successful RDN is not clear.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Resistant in-stent restenosis in the drug eluting stent era

Kleanthis Theodoropoulos MD, Marco G. Mennuni MD, George D. Dangas MD, PhD, Omar A. Meelu MS, Sameer Bansilal MD, MS, Usman Baber MD, MS, Samantha Sartori PhD, Jason C. Kovacic MD, PhD, Pedro R. Moreno MD, Samin K. Sharma MD, Roxana Mehran MD, Annapoorna S. Kini MD

Background: In the drug eluting stent (DES) era, repeat in-stent restenosis (ISR) of the same coronary lesion, despite percutaneous coronary intervention (PCI), is a rare but challenging problem that has not been reported. We aim to describe what we propose as the occurrence of “resistant”-ISR (R-ISR) in the DES era, including angiographic patterns and outcomes.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention

Razi Khan MD, Malek Al-Hawwas MD, Raja Hatem MD, Lorenzo Azzalini MD, Annik Fortier MSC, E. Marc Joliecoeur MD, Jean-Francois Tanguay MD, Philippe Lavoie-L´Allier MD, Hung Q. Ly MD, MSC

Objectives: This study sought to assess the impact of residual coronary artery disease (CAD), using the residual SYNTAX score (rSS), on in-hospital outcomes after primary percutaneous intervention (PPCI). The study also aimed to determine independent predictors for high rSS. Residual CAD has been associated with worsened prognosis in patients undergoing PCI for non-ST acute coronary syndromes. The rSS is a systematic angiographic score that measures the extent and complexity of residual CAD after PCI.

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study

Marco Zimarino MD, PhD, Francesca Angeramo MD, Abhiram Prasad MD, Benedetta Ruggieri MD, Sara Malatesta MD, Francesco Prati MD, Fiamma Buttitta MD, PhD, Raffaele De Caterina MD, PhD

Objectives: To test whether thrombus aspiration (TA) reduces the atherosclerotic burden in culprit lesions and “facilitate” percutaneous coronary intervention with stent (S-PCI) among patients with non-ST elevation acute coronary syndromes (NSTE-ACS).

01 noviembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction

Amirreza Solhpour MD, Kay-Won Chang MD, Salman A. Arain MD, Prakash Balan MD, Yelin Zhao MS, Catalin Loghin MD, James J. McCarthy MD, H. Vernon Anderson MD, Richard W. Smalling MD, PhD

Objectives: We investigated whether prehospital, reduced dose fibrinolysis coupled with urgent percutaneous coronary intervention (FAST-PCI) reduces mortality and cardiac magnetic resonance (CMR) measures of infarct size, compared with primary percutaneous coronary intervention (PPCI), in patients with ST-elevation myocardial infarction (STEMI).

15 septiembre 2016

INTERNATIONAL JOURNAL OF CARDIOLOGY. A systematic review of transcatheter aortic valve implantation via carotid artery access

Thomas Stonier, Michael Harrison, Andrew M.T.L. Choong

Background: The carotid artery is a novel access route for transcatheter aortic valve implantation (TAVI). This may represent a viable alternative in patients unsuitable for TAVI via traditional transfemoral access, up to 20%, as well as other access routes such as subclavian, transapical and aortic. This systematic review summarises the current evidence for its safety and feasibility.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.